Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Velicept Therapeutics
101 Lindenwood Drive, Suite 400
Malvern, PA 19355
Phone: 484-318-2988
http://www.velicept.com/

Velicept Therapeutics, Inc. is a privately held, clinical development company focused on advancing best-in-class compounds with the potential to fill unmet medical needs. Its lead program, solabegron, is a highly differentiated novel compound being investigated for overactive bladder (OAB) and irritable bowel syndrome (IBS). Velicept is a portfolio company of NeXeption. For more information, visit www.velicept.com.

Key Contact
Name
Dr. James C. Walker
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
12/03/15 $21,000,000 Series B CAM Capital
Longitude Capital
undisclosed
10/16/18 $15,000,000 Series B Extension Becker Ventures
CDK Global
Fountain Healthcare Partners
Longitude Venture Partners
Samsara BioCapital
undisclosed


Featured Reading